These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34294725)

  • 1. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
    Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
    Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of erm(C) expression by noninducing antibiotics.
    Bailey M; Chettiath T; Mankin AS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):866-74. PubMed ID: 18086834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
    Champney WS; Tober CL
    Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the rational design of macrolide antibiotics to combat resistance.
    Pavlova A; Parks JM; Oyelere AK; Gumbart JC
    Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide antibiotics allosterically predispose the ribosome for translation arrest.
    Sothiselvam S; Liu B; Han W; Ramu H; Klepacki D; Atkinson GC; Brauer A; Remm M; Tenson T; Schulten K; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9804-9. PubMed ID: 24961372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nascent peptide assists the ribosome in recognizing chemically distinct small molecules.
    Gupta P; Liu B; Klepacki D; Gupta V; Schulten K; Mankin AS; Vázquez-Laslop N
    Nat Chem Biol; 2016 Mar; 12(3):153-8. PubMed ID: 26727240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for six ketolide antibiotics.
    Champney WS; Tober CL
    Curr Microbiol; 2001 Mar; 42(3):203-10. PubMed ID: 11270656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketolides: the future of the macrolides?
    Nilius AM; Ma Z
    Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gene expression by macrolide-induced ribosomal frameshifting.
    Gupta P; Kannan K; Mankin AS; Vázquez-Laslop N
    Mol Cell; 2013 Dec; 52(5):629-42. PubMed ID: 24239289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
    Champney WS; Mentens N; Zurawick K
    Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
    Inoue M; Kaneko K; Nakano R; Sato Y; Arai S
    Jpn J Antibiot; 2004 Oct; 57(5):425-37. PubMed ID: 15655904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the antibiotic action of telithromycin against resistant mutants.
    Berisio R; Harms J; Schluenzen F; Zarivach R; Hansen HA; Fucini P; Yonath A
    J Bacteriol; 2003 Jul; 185(14):4276-9. PubMed ID: 12837804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
    Kannan K; Vázquez-Laslop N; Mankin AS
    Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.